title: Interleukin-2 therapy does not exacerbate multiple sclerosis.
authors.affiliation: Department of Neurology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: B W
authors.initials: BW
authors.lastname: van Oosten
authors.forename: B M
authors.initials: BM
authors.lastname: Uitdehaag
authors.forename: F
authors.initials: F
authors.lastname: Barkhof
authors.forename: H P
authors.initials: HP
authors.lastname: Hartung
authors.forename: J
authors.initials: J
authors.lastname: Wagstaff
authors.forename: C H
authors.initials: CH
authors.lastname: Polman
mesh_terms: D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000556:secondary; D005260:Female; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use*; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000503:physiopathology*
chemical_list: D007376:Interleukin-2